{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:46:57Z","timestamp":1767862017840,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.eplepsyres.2010.04.006","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T04:49:46Z","timestamp":1274417386000},"page":"188-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Interactions of stiripentol with clobazam and valproate in the mouse maximal electroshock-induced seizure model"],"prefix":"10.1016","volume":"90","author":[{"given":"Jarogniew J.","family":"Luszczki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal K.","family":"Trojnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neville","family":"Ratnaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip N.","family":"Patsalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislaw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2010.04.006_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00003495-199448020-00003","article-title":"New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol","volume":"48","author":"Bebin","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle m\u00e9thode simple pour explorer l\u2019action tranquilisante: le test de la chemin\u00e9e","volume":"3","author":"Boissier","year":"1960","journal-title":"Med. Exp. (Basel)"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.0306-5251.2003.01919.x","article-title":"Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human","volume":"56","author":"Cazali","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl. 6","key":"10.1016\/j.eplepsyres.2010.04.006_bib4","first-page":"73","article-title":"Multifocal epilepsy in infancy: value of stiripentol\u2013clonazepam combination","volume":"34","author":"Chiron","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib5","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial, STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molbrainres.2005.09.010","article-title":"Molecular regulation of glutamate and GABA transporter proteins by clobazam during epileptogenesis in Fe(+++)-induced epileptic rats","volume":"142","author":"Doi","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1528-1157.1993.tb02416.x","article-title":"Stiripentol in atypical absence seizures in children: an open trial","volume":"34","author":"Farwell","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.06.004","article-title":"The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator","volume":"56","author":"Fisher","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(24)35017-7","article-title":"Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures","volume":"290","author":"Gasior","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/dmd.105.007237","article-title":"In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism","volume":"34","author":"Giraud","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib11","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1528-1167.2009.02179.x","article-title":"Stiripentol open study in Japanese patients with Dravet syndrome","volume":"50","author":"Inoue","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1528-1167.2007.01423.x","article-title":"Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data","volume":"49","author":"Kassa\u00ef","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1528-1157.1991.tb05254.x","article-title":"Carbamazepine dose requirements during stiripentol therapy: influence of cytochrome P-450 inhibition by stiripentol","volume":"32","author":"Kerr","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/clpt.1984.237","article-title":"Stiripentol kinetics in epilepsy: nonlinearity and interactions","volume":"36","author":"Levy","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1528-1157.1985.tb05715.x","article-title":"Stiripentol in acute\/chronic efficacy tests in monkey model","volume":"26","author":"Lockard","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib17","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib18","first-page":"618","article-title":"Randomized double-blind, parallel, multicenter trial of stiripentol added to carbamazepine in the treatment of carbamazepine-resistant epilepsies: an interim analysis","volume":"31","author":"Loiseau","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-1211(02)00073-6","article-title":"Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy","volume":"50","author":"L\u00f6scher","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00210-007-0144-z","article-title":"Isobolographic analysis of interaction between drugs with nonparallel dose\u2013response relationship curves: a practical application","volume":"375","author":"Luszczki","year":"2007","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-004-0867-z","article-title":"Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study","volume":"369","author":"Luszczki","year":"2004","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00210-006-0100-3","article-title":"Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis","volume":"374","author":"Luszczki","year":"2006","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"issue":"Suppl. 11","key":"10.1016\/j.eplepsyres.2010.04.006_bib25","first-page":"365","article-title":"Effect of WIN 55,212-2 mesylate\u2014a highly potent cannabinoid CB1 and CB2 receptor agonist on the protective action of carbamazepine, phenytoin, phenobarbital and valproate in the mouse maximal electroshock-induced seizure model","volume":"50","author":"Luszczki","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(03)00081-9","article-title":"Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice","volume":"75","author":"Luszczki","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib27","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.npp.1300243","article-title":"Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice","volume":"28","author":"Luszczki","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.npp.1300602","article-title":"Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"30","author":"Luszczki","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.yebeh.2005.07.007","article-title":"Pharmacodynamic and\/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"7","author":"Luszczki","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib30","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/j.1528-1167.2006.00825.x","article-title":"Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis","volume":"47","author":"Luszczki","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00210-006-0055-4","article-title":"Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"373","author":"Luszczki","year":"2006","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib32","first-page":"155","article-title":"Stiripentol in a dose-dependent manner elevates the threshold for maximal electroshock-induced seizures in mice","volume":"1","author":"Luszczki","year":"2007","journal-title":"J. Pre-Clin. Clin. Res."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2008.11.049","article-title":"Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"602","author":"Luszczki","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib34","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav. Toxicol."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib35","first-page":"709","article-title":"Effect of stiripentol on petit mal-like epilepsy in Wistar rats","volume":"29","author":"Micheletti","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.nurt.2006.11.002","article-title":"Clobazam","volume":"4","author":"Ng","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib37","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib38","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1528-1157.1999.tb02048.x","article-title":"Stiripentol: efficacy and tolerability in children with epilepsy","volume":"40","author":"Perez","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib39","first-page":"199","article-title":"A new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical study","volume":"34","author":"Poisson","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib40","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1528-1167.2006.00497.x","article-title":"Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-receptor channels","volume":"47","author":"Quilichini","year":"2006","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1016\/j.eplepsyres.2010.04.006_bib41","first-page":"74","article-title":"Single-blind add-on trial of stiripentol in epileptic children","volume":"34","author":"Renard","year":"1993","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.eplepsyres.2010.04.006_bib42","first-page":"112","article-title":"Stiripentol potentiates clobazam in childhood epilepsy: a pharmacological study","volume":"40","author":"Rey","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0031-6997(25)00046-8","article-title":"Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds","volume":"42","author":"Rogawski","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0920-1211(90)90052-W","article-title":"Efficacy of stiripentol in the intravenous pentylenetetrazol infusion seizure model in the rat","volume":"7","author":"Shen","year":"1990","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0920-1211(92)90088-B","article-title":"Comparative anticonvulsant potency and pharmacokinetics of (+)- and (\u2212)-enantiomers of stiripentol","volume":"12","author":"Shen","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib46","series-title":"Drug Synergism and Dose-Effect Data Analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0009-9236(97)90044-8","article-title":"Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constants","volume":"62","author":"Tran","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib49","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0924-977X(93)90265-N","article-title":"Effects of valproate on early and late potassium currents of single neurons","volume":"3","author":"Walden","year":"1993","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.eplepsyres.2010.04.006_bib51","first-page":"455","article-title":"Pharmaco-cellular enzymology of the mechanism of action of stiripentol in cardiazol-induced epilepsy. III. Protein, nucleoprotein, lipid, and proteoglycan metabolism","volume":"23","author":"Wegmann","year":"1978","journal-title":"Cell. Mol. Biol. Incl. Cyto Enzymol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121110001130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121110001130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:23:28Z","timestamp":1760275408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121110001130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0920121110001130"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2010.04.006","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions of stiripentol with clobazam and valproate in the mouse maximal electroshock-induced seizure model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2010.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}